Comparative effects of several nitric oxide donors on intracellular cyclic GMP levels in bovine chromaffin cells: Correlation with nitric oxide production

British Journal of Pharmacology

Volumn 127, Issue 3, 1999, Pages 779-787

  Ferrero, Rut ^a   Rodriguez Pascual, Fernando ^a   Miras Portugal, Ma Teresa ^a   Torres, Magdaiena ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cyclic GMP; Nitric oxide donors; Nitric oxide measurements; NONOates; SNAP; Sodium nitroprusside

Indexed keywords

CYCLIC GMP; GLUTATHIONE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; SPERMINE;

ANIMAL CELL; ARTICLE; CATTLE; CHROMAFFIN CELL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DECOMPOSITION; DRUG POTENCY; HALF LIFE TIME; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CATTLE; CELLS, CULTURED; CHROMAFFIN CELLS; CYCLIC GMP; HYDRAZINES; INTRACELLULAR FLUID; KINETICS; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROGEN OXIDES; NITROPRUSSIDE; PENICILLAMINE; SPERMINE;

EID: 0033024993     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702607     Document Type: Article

References (42)

1. BATES, J.N., BAKER, M.T., GUERRA, R. & HARRISON, D.O. (1992). Chemical release of nitric oxide from sodium nitroprusside to nitric oxide in vascular smooth muscle. J. Pharmacol. Exp. Ther., 262,916-922.
2. CHEN, C. & SCHOFIELD, G.G. (1993). Nitric oxide modulates Ca2 + channel currents in rat sympathetic neurons. Eur. J. Pharmacol., 243,83-86.
3. DAVIS, J.P., VO, X.T. & SULAKLHE, P.V. (1997). Altered responsiveness of guanylyl cyclase to nitric oxide following treatment of cardiomyocytes with S-nitroso-D,L-acetylpenicillamine and sodium nitroprusside. Biochem. Biophys. Res. Commun., 238, 351-356.
4. DESOLE, M.S., KIM, W.K., RABIN, R.A. & LAYCHOCK, S.C. (1994).
5. Nitric oxide reduces depolarization-induced calcium influx in PC12 cells by a cyclic GMP-mediated mechanism. Neuropharmacology. 33, 193-198.
6. DICKS, A.P., SWIFT, H.R., WILLIAMS, D.L.H., BUTLER, A.R., ALSA1 DONI, H.H. & COX, B.C. (1996). Identification of Cu+ as the effective reagent in nitric oxide formation from S-nitrosothiols (RSNO). J. Client. Soc. Prekin Trans., 2, 481-487.
7. FEELICH, M. & NOACK, E.A. (1987). Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. Eur. J. Pharmacol.. 139, 19-30.
8. FÖRSTERMAN, U., OATH, L, SCHWARZ, P., CLOSS, E.I. & KLEINERT, H. (1995). Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem. Pharmacol., 50, 1312-1332.
9. FRIEBE, A., SCHULTZ, G. & KOESLING, D. (1996). Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBOJ., 24, 6863-6868.
10. GOLDSTEIN, S. & CZAPSKI, G. (1995). Kinetics of nitric oxide autooxidation in aqueous solution in the absence and presence of various reductants. The nature of the oxidizing intermediates. J. Am. Chem. Soc., 117, 12078-12084.
11. GORDGE, M.P., MEYER, D.J., HOTHERSHALL, J., NEILD, G.H., PAYNE, N.N. & NORONHA-DUTRA, A. (1996). Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione. Br. J. Pharmacol., 114, 1083-1089.
12. HADDAH, I.Y., CROW, J.P., HU, P., YE, Y., BECKMAN, J.S. & MATALON, S. (1994). Concurrent generation of nitric oxide and Superoxide damages surfactant protein A. Am. J: Physiol., 11, L242-L249.
13. HENRY, Y., LEPOIVRE, M., DRAPIER, J-C, DUCROCQ, C, BOUCHER, J-L. & GUISSANI, A. (1993). EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEBJ.,1, 1124-1134.
14. HEVEL, J.M. & MARLETTA, M.A. (1994). Nitric-oxide synthase assays. Methods Eiuymol.. 233, 250-258.
15. IGNARRO, L.J., DEGNAN, J.N., BARICOS, W.U., KADOWITZ, P.J. & WOLIN, M.S. (1982). Activation of purified soluble guanylate cyclase by nitric oxide requires heme: comparison of hemedeficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim. Biophys. Acta, 718, 49-59.
16. IOANNIDIS, I., BÄTZ, M., PAUL, T., KORTH, H-G., SUSTMANN, R. & DEGROOT, H. (1996). Enhanced release of nitric oxide causes increased cytotoxicity of S-nitroso-N-acetyI-D,L-penicillamine and sodium nitroprusside under hypoxic conditions. Biochem. J., 318, 789-795.
17. KAYE, D.M., W1VIOTT, S.D., KOBZIK, L., KELLY, R.A. & SMITH, T.H. (1997). S-nitrosothiols inhibit neuronal norepinephrine transport. Am. J. Physiol.. 272, H875-H883.
18. KEEPER, L.K., NIMS, R.W., DAVIES, K.M. & WINK, D.A. (1996). 1 NONOates1 (1-substituted Diazen-l-ium-l,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Emymol., 268, 281-293.
19. KHARITONA, V.O., SUNQUIST, A.R. & SHARMA, V.S. (1994). Kinetics of nitric oxide auto-oxidation in aqueous solution. J. Biol. Chem.. 269, 5881-5883.
20. KNOWLES, R.G., PALACIOS, M., PALMER, R.M.J. & MONCADA, S. (1990). Kinetic characteristics of nitric oxide synthase from rat brain. Biochem. J., 269, 207-210.
21. LÄFARS, G. & GYLLENHAMMAR, K. (1995). Measurement of methemoglobin formation from oxyhemoglobin. A real-time, continuous assay of nitric oxide release by human polymorphonuclear leukocytes. J. Immunol. Methods, 184, 53-62.
22. LAURENT, M., LEPOIVRE, M. & TENU, J.P. (1996). Kinetic modelling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase. Biochem. J., 314,109 113.
23. LIPTON, S.A., CHOI, Y.B., PAN, Z.H., LEI, S.Z., VINCENT CHEN, U.S., SUCHER, N.J., LOSCALZO, J., SINGEL, D.J. & STAMLER, J.S. (1993). A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroscompounds. Nature, 364, 626-632.
24. MALINSKI, T. & TAHA, Z. (1992). Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature, 358,676-678.
25. MARAGOS, CM., MORLEY, D., WINK, D.A., DUNAMS, T.M., SAAVEDRA, J.E., HOFFMAN, A., BOVE, A.A., ISAAC, L., HRABIE, J.A. & KEEPER, L.K. (1991). Complexes of NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J. Med. Chem., 34, 3242-3247.
26. MATTHEWS, J.R., BOTTING, C.H., PANICO, M., MORRIS, H.R. & HAY, T. (1996). Inhibition of NF-kB DNA binding by nitric oxide. Nucleic. Acids. Res., 24, 2236-2242.
27. MAYER, B., SCHRAMMEL, A., KLATT, P., KOESLING, D. & SCHMIDT, K. (1995). Peroxynitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified guanylyl cyclase. Dependence on glutathione and possible role of S-nitrosation. J. Biol. Client., 270, 17355-17360.
28. MISKO, T.P., SCHILLING, R.J., SAVEMINI, D., MOORE, W.M. & CURRIE, M.A. (1993). A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biocheni., 214, 11-16.
29. MONCADA, S., PALMER, R.M.J. & HIGGINS, E.A. (1991). Nitric oxide, pathophysiology, pathophysiology and pharmacology. Pharmacol Rev., 43, 109-142.
30. MURAD, F. (1986). Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest., 78, 1-5.
31. MURPHY, M.E. & NOACK, E. (1994). Nitric oxide assay using hemoglobin method. Methods Enzymol., 233, 240-250.
32. RAMAMURTHI, A. & LEWIS, R.S. (1997). Measurement and modeling of nitric oxide release rates for nitric oxide donors. Chem. Res. ToxicoL, 10,408-413.
33. RAO, D.N.R., ELGUINDI, S. & O1 BRIEN, P.J. (1991). Reductive metabolism of nitroprusside in rat hepatocytes and human erythrocytes. Arch. Biocheni. Biophys., 286, 30-37.
34. RODRIGUEZ-PASCUAL, F., MIRAS-PORTUGAL, M.T. & TORRES, M. (1995). Activation of NOrcGMP pathway by acetylcholine in bovine chromaffin cells. Possible role of Ca2"1" in the downregulation of cGMP signaling. Biochem. Pharmacol., 50, 763769.
35. RODRIGUEZ-PASCUAL, F., MIRAS-PORTUGAL, M.T. & TORRES, M. (1996). Effect of cyclic GMP-increasing agents nitric oxide and Ctype natriuretic peptide on bovine chromaffin cell function: Inhibitory role mediated by cyclic GMP-dependent protein kinase. Mol. Pharmacol., 49, 1058-1070.
36. SCHMIDT, K., DESCH, W., KLATT, P., KUKOVETZ, W.R. & MAYER, B. (1997). Release of nitric oxide from donors with known halflife: a mathematical model for calculating nitric oxide concentrations in aerobic solutions. Naunyn Schmiedeberg1 s Arch. Pharmacol., 355,457-462.
37. SCHWARZ, P.M., RODRIGUEZ-PASCUAL, F., KOESLING, D., TORRES, M. & FÖRSTERMANN, U. (1998). Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells. Neuroscience, 82, 255-265.
38. SINGH, R.J., HOGG, N., JOSEPH, J. & KALYNARAMAN, B. (1996). Mechanism of nitric oxide release from S-nitrosothiols. J. Biol. Chem.,n\, 18596-18603.
39. SOUTHAM, E. & GARTHWAITE, J. (1991). Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices. Neuroscience Lett., 130, 107-111.
40. STONE, J.R. & MARLETTA, M.A. (1996). Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry. 35, 1093-1099.
41. WALDMAN, S.A. & MURAD, F. (1987). Cyclic GMP synthesis and function. Pharmacol. Rev., 39, 163-196.
42. WILSON, S.P. (1987). Purification of adrenal chromaffin cells on renografin gradients. J. Neurosci. Melhods, 19, 163-171.